announces

Dyne Therapeutics Announces Upcoming Presentations Across Neuromuscular Pipeline at 2026 MDA Clinical & Scientific Conference

February 22, 2026 16:00 ET  | Source: Dyne Therapeutics, Inc. - Late-breaking poster to feature new positive cardiopulmonary function results…

1 month ago

Gyder Surgical announces first commercial surgical cases in the United States performed by Dr. Paul M. Lombardi, M.D., at the Tri-County Orthopedics Joint Replacement Institute outpatient center

PALO ALTO, Calif. and MULGRAVE, Australia, Feb. 22, 2026 (GLOBE NEWSWIRE) -- Gyder Surgical, a MedTech company specializing in intuitive, non-invasive…

1 month ago

Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option

February 20, 2026 15:10 ET  | Source: Eupraxia Pharmaceuticals Inc. VICTORIA, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eupraxia…

2 months ago

VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025

February 20, 2026 19:11 ET  | Source: VERSES AI Inc. VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- VERSES…

2 months ago

Constellation Software Inc. Announces Change to the Date of the Conference Call to Discuss Fourth Quarter Results

February 20, 2026 17:16 ET  | Source: Constellation Software Inc. TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Constellation Software Inc.…

2 months ago

Bel Fuse Inc. Announces Regular Quarterly Cash Dividend on its Class A and Class B Shares

February 20, 2026 16:49 ET  | Source: Bel Fuse Inc. WEST ORANGE, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- BEL…

2 months ago

Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates

2025 Total Revenue of $634M, up 17% Year-over-Year at CER Cash Position of $294M, a $44M Increase in 2025 Proposed…

2 months ago

aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: ATYR) (“aTyr” or “the Company”), a clinical stage…

2 months ago

Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million

Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share Private Placement Up to $1.0 Million Intended to Support…

2 months ago

Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…

2 months ago